ArticleOncotarget2020

Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin.

Gleb Baida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.